Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study
- 31 July 2011
- journal article
- Published by Elsevier in Metabolism
- Vol. 60 (7) , 987-993
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical ApplicationsAnnals of Internal Medicine, 2010
- Leptin and Soluble Leptin Receptor Levels in Plasma and Risk of Type 2 Diabetes in U.S. WomenDiabetes, 2009
- Circulating Ghrelin, Leptin, and Soluble Leptin Receptor Concentrations and Cardiometabolic Risk Factors in a Community-Based SampleThe Journal of Clinical Endocrinology & Metabolism, 2008
- Regulation of Circulating Soluble Leptin Receptor Levels By Gender, Adiposity, Sex Steroids, and LeptinDiabetes, 2002
- Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human BloodBiochemical and Biophysical Research Communications, 2001
- LeptinAnnual Review of Physiology, 2000
- Leptin: its pharmacokinetics and tissue distributionInternational Journal of Obesity, 1998
- Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.Journal of Clinical Investigation, 1996
- Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese HumansNew England Journal of Medicine, 1996
- Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissueDiabetes, 1995